Published in Medical Letter on the CDC and FDA, February 22nd, 1999
Merozoite surface protein 1 is a candidate for blood-stage vaccines against parasites that cause malaria.
Chunfu Yang, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, and colleagues performed an immunization study of Saimiri monkeys with a yeast-expressed recombinant protein ("Partial Protection against Plasmodium vivax Blood-Stage Infection in Saimiri Monkeys by Immunization with a Recombinant C-Terminal Fragment of Merozoite Surface Protein 1 in Block Copolymer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA